Solpecainol hydrochloride

N/A

Report date: 2022/02/11 14:54:00
NME

Base Information

Drug NameSolpecainol hydrochloride
Drug Alias NameEGIS-2936EGYT-2936
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsAngina PectorisArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEgis Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEgis Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsAngina PectorisArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A